August 20, 2024

Tyrosine kinase inhibitor clinical approval

Drug Approval News: The FDA has approved JNJ’s Rybrevant® (Amivantamab-vmjw plus Lazertinib) as a first line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer. Lazertinib […]
August 2, 2024

World RNA Day

August 1st is World RNA Day and Focus Biomolecules is celebrating! Check out our broad portfolio of small molecule research tools for studying RNA. Don’t see […]
July 29, 2024

TRPV1 review

Journal Club: An excellent review of the TRPV1 channel was recently published in Cell Calcium, covering its structure, activation, and modulation, as well as its role […]
July 18, 2024

On Ivermectin and others

Focus on Natural Products: Celebrating the birthday of Satoshi Omura (July 12). Omura is well known for his work on the isolation and structure identification of […]
July 12, 2024

Bedaquiline and TB, COVID

Drug Approval News: Johnson & Johnson (J&J) has received approvals from both the European Commission (EC) and US Food and Drug Administration (FDA) for its tuberculosis […]
July 12, 2024

Mitochondrial complex III inhibitor

Natural Product Cellular Probes. Ascochlorin is a novel isoprenoid isolated from Acremonium egyptiacum. It is a specific inhibitor of the mitochondrial cytochrome bc1 complex (mitochondrial respiratory […]
July 9, 2024

DNA Topoisomerase I inhibitors

Natural Product-Inspired Drugs. Camptothecin, an alkaloid isolated from Camptotheca acuminata, is a potent inhibitor of DNA topoisomerase I. Numerous useful analogs of camptothecin have been synthesized: […]
July 9, 2024

Microcystin-LR improves anti-tumor efficacy of oxaliplatin

Focus on Natural Products: Microcystin LR, a cyanobacterial toxin that inhibits protein phosphatase 2A, was recently shown to stimulate tumor-associated macrophages to adopt an anti-tumor M1 […]
June 27, 2024

Gut microbial metabolites

On World Microbiome Day (June 27, 2024) we focus on gut microbial metabolites. Phenylacetyl-L-glutamine (PAGln) was shown to be a cardiovascular disease-linked gut microbial metabolite acting […]